| Literature DB >> 11352676 |
A Tiwari1, H J Salacinski, G Hamilton, A M Seifalian.
Abstract
Surgical treatment of vascular disease has become common. The use of synthetic materials is limited to grafts larger than 5-6 mm, because of the frequency of occlusion observed with small-diameter prosthetics. An alternative would be a hybrid or tissue-engineered graft with the surface coated with a monolayer of the patients' own endothelial cells. This review examines the various techniques and technologies used to date in order to extract endothelial cells for such graft engineering. Copyright 2001 Harcourt Publishers Limited.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11352676 DOI: 10.1053/ejvs.2001.1316
Source DB: PubMed Journal: Eur J Vasc Endovasc Surg ISSN: 1078-5884 Impact factor: 7.069